Forward Pharma A/S
FWPAY · OTC
6/30/2022 | 12/31/2021 | 6/30/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $37 | $48 | $69 | $56 |
| - Cash | $65 | $71 | $75 | $79 |
| + Debt | $3 | $0 | $0 | $0 |
| Enterprise Value | -$26 | -$23 | -$6 | -$23 |
| Revenue | – | – | – | – |
| % Growth | – | – | – | – |
| Gross Profit | – | – | – | – |
| % Margin | – | – | – | – |
| EBITDA | – | – | – | – |
| % Margin | – | – | – | – |
| Net Income | – | – | – | – |
| % Margin | – | – | – | – |
| EPS Diluted | – | – | – | – |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |